ClinicalTrials.gg
RecruitingNCT07767149Updated Nov 10, 2026

Effects of Flavonoid Foods on Carbonyl Stress

An interventional study of High-Flavonoid Diet and Low-Flavonoid Diet in Human Health, Flavonoids and Carbonyl Stress, sponsored by North Carolina Agriculture & Technical State University. Recruiting at 1 site in United States. Open to participants aged 25 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by North Carolina Agriculture & Technical State University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
25 Years to 70 Years
Sex
All
01

Study summary

This randomized crossover study will compare low- and high-flavonoid diets in healthy adults to identify flavonoid-derived biomarkers in urine and plasma. Using targeted liquid chromatography-mass spectrometry (LC-MS) metabolomics, researchers will measure known and novel flavonoid metabolites and evaluate whether a higher flavonoid intake reduces carbonyl stress markers, including reactive carbonyl species (RCS) and advanced glycation end products (AGEs).

Read the detailed description

Biomarkers of flavonoids and flavonoid-rich foods are needed to monitor diets. Monitoring diets and associating dietary patterns with health risks and outcomes is an essential step in the research process. The goal of this study is to determine the time- and dose-dependent formation of novel flavonoid metabolites in urine and plasma samples by conducting a randomized crossover trial of two dietary interventions with low (\~140 mg flavonoids/day) and high (\~420 mg flavonoids/day) flavonoid diets among healthy individuals.

Foods with high or low flavonoid content will be incorporated into participants' usual diets. Liquid chromatography-mass spectrometry (LCMS)-based targeted metabolomics will be used to assess flavonoid metabolites, including novel RCS-conjugated and oxidized flavonoid metabolites, and to determine whether consuming a flavonoid-rich diet will lead to a decrease in carbonyl stress as measured by RCS and related advanced glycation end products (AGEs). Investigators will determine the changes in the major RCS and related AGEs after each intervention period using LCMS and examine the relationship between changes in RCS and AGEs and the formation of flavonoid RCS conjugates

02

Conditions studied

  • Human Health
  • Flavonoids
  • Carbonyl Stress

Keywords

  • flavonoids
  • Carbonyl stress
  • Advanced glycation end products (AGEs)
  • Metabolomics
  • Reactive carbonyl species (RCS)
03

In context

Lead sponsor

North Carolina Agriculture & Technical State University is the lead sponsor of 12 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 25-70 years
  • between 18 and 30
  • Have no known allergy to test food
  • Have no known allergies to green tea, apples, blueberries, soy milk, or pineapples
  • Be not engaging in high-intensity exercise
  • Having blood and urine clinical tests in the normal range.
  • Be not taking antibiotics for six months
  • Be not currently taking medication
  • No taking any prescription drugs
  • All flavonoid-enriched supplements should be avoided. The flavonoid-enriched supplements list includes soy isoflavones, Lipo-Flavonoid, Citrus Bioflavonoids Complex, Super Flavonoids, Super Antioxidants, Quercetin Supplement, Essential-C, flavonoids, and milk thistle. Also other flavonoid supplements, including but not limited to luteolin, Rutin, etc.
  • No drugs or supplements within three weeks of the experiment
  • Be nonsmoking
  • Have no alcoholic intoxication
  • No alcoholic addiction
  • \< 3-4 drinks per week (less than 2 glasses (300 mL) per drink)
  • No alcohol within three weeks of the experiment
  • Have no extended exposure to industrial wastes

Exclusion criteria

Exclusion Criteria:

  • Disease: gout, heart disease, peripheral vascular disease, degenerative kidney, degenerative liver, diabetes, GI disorders, or endocrine disorders
  • Cancer patients
  • Currently diagnosed cancer patients will be excluded.
  • Medication-free for >2 years could be considered.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    High-Flavonoid Diet, Then Low-Flavonoid Diet

    All participants will first complete a 2-week low-flavonoid wash-in period. Participants in this sequence will then consume the high-flavonoid diet for 3 weeks, complete a 3-week low-flavonoid washout period, and then consume the low-flavonoid diet for 3 weeks.

    Dietary Supplement: High-Flavonoid Diet · Dietary Supplement: Low-Flavonoid Diet

  • Experimental
    Low-Flavonoid Diet Followed by High-Flavonoid Diet

    All participants will first complete a 2-week low-flavonoid wash-in period. Participants in this sequence will then consume the low-flavonoid diet for 3 weeks, complete a 3-week low-flavonoid washout period, and then consume the high-flavonoid diet for 3 weeks.

    Dietary Supplement: High-Flavonoid Diet · Dietary Supplement: Low-Flavonoid Diet

Interventions

  • Dietary supplementHigh-Flavonoid Diet

    Participants will consume the high-flavonoid diet daily for 3 weeks. The diet includes 1 Red Delicious apple (approximately 160 g), freeze-dried whole blueberry powder (25 g), soy milk (240 mL), and decaffeinated Lipton green tea ( 2 g tea leaves), providing approximately 420 mg flavonoids per day.

  • Dietary supplementLow-Flavonoid Diet

    Participants will consume the low-flavonoid diet daily for 3 weeks. The diet includes 1/3 of Red Delicious, 107 g of pineapple; 8.3 g of blueberry powder plus 16.7 g of blueberry placebo powder; 80 mL of soy milk plus 160 mL of 2% low-fat milk; and 0.67 g tea leaves, providing approximately 140 mg flavonoids per day.

06

What researchers measure

Primary outcomes

  1. Plasma and Urine Flavonoid Metabolites

    Change in plasma and urine concentrations of flavonoid metabolites, including reactive carbonyl species (RCS)-conjugated flavonoid metabolites, measured by liquid chromatography-mass spectrometry (LC-MS).

    Time frame: After the 3-week dietary intervention period.

Secondary outcomes

  1. Association Between Carbonyl Stress Biomarkers and Flavonoid RCS Conjugates

    Association between changes in urinary reactive carbonyl species and the formation of flavonoid RCS-conjugated metabolites measured by liquid chromatography-mass spectrometry (LC-MS).

    Time frame: After the 3-week dietary intervention

07

Study locations

1 of 1 sites recruiting
  • North Carolina Agriculture and Technical State University/ NRI Building
    Kannapolis, North Carolina 28081, United States
    Recruiting
08

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: date precision
1 update, last Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Minor edits only
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07767149
Lead sponsor
North Carolina Agriculture & Technical State University
Responsible party
Shengmin Sang (Distinguished Professor, North Carolina Agriculture & Technical State University) — Principal investigator
First posted
Aug 17, 2026
Start date
Sep 2, 2026
Primary completion
Oct 15, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Shengmin Sang
Contact
ssang@ncat.edu
704-250-5710
Shengmin Sang
principal investigator · North Carolina A&T State University Principal Investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion